Full name
"ROLVET" JÓZEF I BARBARA NAPIERAŁA SPÓŁKA JAWNA
uses securityreCAPTCHA
"ROLVET" JÓZEF I BARBARA NAPIERAŁA SPÓŁKA JAWNA
UL. NOWOTOMYSKA 33, 64-310 LWÓWEK
TAX ID7881348616
Rate company:
"ROLVET" JÓZEF I BARBARA NAPIERAŁA SPÓŁKA JAWNA
TAX ID7881348616
KRS0000030547
address
UL. NOWOTOMYSKA 33, 64-310 LWÓWEK
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7881348616
REGON
004795350
KRS
0000030547
Legal form
general partnership
Register Address
UL. NOWOTOMYSKA 33, 64-310 LWÓWEK
Date of registration in KRS
2001-07-27
Date of commencement of economic activity
2001-07-27
Act signature
RDF/614877/24/834
Pkd codes
46.46.Z - Wholesale of pharmaceutical goods
46.21.Z - Wholesale of grain, unmanufactured tobacco, seeds and animal feeds
46.75.Z - Wholesale of chemical products
46.76.Z - Wholesale of other intermediate products
47.78.Z - Other retail sale of new goods in specialised stores
47.99.Z - Other retail sale not in stores, stalls or markets
52.10.B - Warehousing and storage of other goods
82.99.Z - Other business support service activities not elsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL40 1090 1388 0000 0000 3800 9240 
PL63 1090 1388 0000 0001 1127 7000 PL77 1090 1362 0000 0001 3490 9597 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 1,8 | 1,2 | -0,2 | -115,9 |
EBITDA | 1,9 | 1,2 | -0,1 | -108,7 |
Short time liabilities | 2,2 | 1,4 | 3,4 | 139,4 |
Equity capital | 3,8 | 3,9 | 2,9 | -26,7 |
Operating profit (EBIT) | 1,9 | 1,2 | -0,2 | -118,7 |
Assets | 6,4 | 5,8 | 6,3 | 7,8 |
Net profit (loss) | 1,8 | 1,2 | -0,2 | -115,9 |
Cash | 0,4 | 0,2 | 0,2 | -9,7 |
Net income from sale | 28,5 | 23,7 | 29,4 | 24,1 |
Liabilities and provisions for liabilities | 2,6 | 1,9 | 3,4 | 79,4 |
Working assets | 6,4 | 5,8 | 6,2 | 7,6 |
Depreciation | 0 | 0 | 0,1 | 162,9 |
% | % | % | p.p. | |
Profitability of capital | 48,8 | 30,3 | -6,6 | -36,9 |
Equity capital to total assets | 59,2 | 67,5 | 45,9 | -21,6 |
Gross profit margin | 6,5 | 5 | -0,6 | -5,6 |
EBITDA Margin | 6,7 | 5,2 | -0,4 | -5,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 28 | 22 | 42 | 20 |
Current financial liquidity indicator | 2.9560317993164062 | 4.030862808227539 | 1.8270598649978638 | -2,2 |
Net dept to EBITDA | 0.7053454518318176 | 0.19940824806690216 | 1.7831393480300903 | 1,6 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfuses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Joanna Deszczyńska
Biskupiec
ADO-MED Sp. z o.o.
Świętochłowice
Med Digital sp. z o.o.
Warszawa
Grand - Med Janina Pławska
Racław
HS Medical Poland
Tychy